RNTX — Rein Therapeutics Share News
0.000.00%
Last trade - 00:00Rein Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Rein Therapeutics Q2 net loss narrows on lower R&D spending
Rein Therapeutics Inc expected to post a loss of 17 cents a share - Earnings Preview
Brief: Rein Therapeutics Announces Closing Of $57.5 Million Underwritten Public Offering
Brief: Rein Therapeutics Inc Prices Public Offering Of 50 Million Shares At $1.00 Per Share For $50 Million
Brief: Rein Therapeutics Provides Clinical Trial Update For Phase 2 Renew Study Of Lti-03 In Idiopathic Pulmonary Fibrosis
Brief: Rein Therapeutics Doses First Patient In Phase 2 Trial Of Lti-03 For Idiopathic Pulmonary Fibrosis
U.S. STOCKS ON THE MOVE-Moderna, Seagate, Western Digital
U.S. STOCKS ON THE MOVE -Alignment Healthcare, Capricor Therapeutics, silver miners
U.S. STOCKS ON THE MOVE-Netflix, ServiceNow, D.R. Horton
Rein Therapeutics rises as drug for lung‑scarring disease gets EU orphan status
Brief: Rein Therapeutics Receives European Regulatory Approval To Initiate Phase 2 Trial Of LTI-03 In Idiopathic Pulmonary Fibrosis
Brief: Rein Therapeutics Files Prospectus Related To Offer And Sale Of Up To 10 Million Shares Of Common Stock By Selling Stockholder- SEC Filing
Rein Therapeutics Inc expected to post a loss of 25 cents a share - Earnings Preview
Rein Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Rein Therapeutics Inc expected to post a loss of 22 cents a share - Earnings Preview
Brief: Rein Therapeutics Enters Into Agreements For Up To $21 Million In Flexible Financing
U.S. STOCKS ON THE MOVE-Bunge, Northern Oil and Gas, AIRO Group
U.S. STOCKS ON THE MOVE- Northern Oil and Gas, AIRO Group, Whirlpool